Skip to main content
. 2025 Sep 2;17(9):1149. doi: 10.3390/pharmaceutics17091149
DPI Dry powder for inhalation
NGI Next generation impactor
OIDP Orally inhaled drug product
Cmax Maximum plasma concentration
Tmax Time to maximum plasma concentration
AUC0–4 Area under plasma concentration-time curve from zero to four hours post-dose
AUC0–t Area under the plasma concentration-time curve from zero to the last observed concentration
AUC0–∞ Area under plasma concentration-time curve from zero to infinity
t1/2 Plasma concentration half-life
SD Standard deviation